Trading Members are hereby informed that the trading in the equity shares of Onesource Specialty Pharma Ltd. (Formerly Known as Stelis Biopharma Limited) (BSE Scrip code: 544292) shall be permitted under ‘B’ group with effect from w.e.f. Thursday, February 06, 2025.
Ashok Kumar Singh
Deputy General Manager
|